In breast cancer, most oncogenic alterations were enriched in TMB and bTMB≥10 samples, with the notable exception of ESR1, consistent with hormone-receptor positive breast cancer having lower TMB than other subtypes (Fig. 3C). This evidence concerns the gene ESR1 and breast carcinoma.